Annual Total Long Term Liabilities
$2.07 M
+$2.07 M+100.00%
December 1, 2023
Summary
- As of March 9, 2025, BLAC annual total long term liabilities is $2.07 million, with the most recent change of +$2.07 million (+100.00%) on December 1, 2023.
- During the last 3 years, BLAC annual total long term liabilities has risen by +$2.07 million (+100.00%).
Performance
BLAC Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.07 M
$0.000.00%
September 1, 2024
Summary
- As of March 9, 2025, BLAC quarterly total long term liabilities is $2.07 million, unchanged on September 1, 2024.
- Over the past year, BLAC quarterly long term liabilities has stayed the same.
Performance
BLAC Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BLAC Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | 0.0% |
| 3 y3 years | +100.0% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
BLAC Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Bellevue Life Sciences Acquisition Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.07 M(0.0%) |
| Jun 2024 | - | $2.07 M(0.0%) |
| Mar 2024 | - | $2.07 M(0.0%) |
| Dec 2023 | $2.07 M | $2.07 M(0.0%) |
| Sep 2023 | - | $2.07 M(0.0%) |
| Jun 2023 | - | $2.07 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.07 M(>+9900.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00 |
| Dec 2020 | $0.00 | - |
FAQ
- What is Bellevue Life Sciences Acquisition annual total long term liabilities?
- What is the all time high annual total long term liabilities for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual total long term liabilities year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly long term liabilities year-on-year change?
What is Bellevue Life Sciences Acquisition annual total long term liabilities?
The current annual total long term liabilities of BLAC is $2.07 M
What is the all time high annual total long term liabilities for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual total long term liabilities is $2.07 M
What is Bellevue Life Sciences Acquisition annual total long term liabilities year-on-year change?
Over the past year, BLAC annual total long term liabilities has changed by +$2.07 M (+100.00%)
What is Bellevue Life Sciences Acquisition quarterly total long term liabilities?
The current quarterly long term liabilities of BLAC is $2.07 M
What is the all time high quarterly long term liabilities for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly total long term liabilities is $2.07 M
What is Bellevue Life Sciences Acquisition quarterly long term liabilities year-on-year change?
Over the past year, BLAC quarterly total long term liabilities has changed by $0.00 (0.00%)